Difference between revisions of "LncRNAWiki:Hemic and Lymphatic Diseases"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Disease !width="50"|LncRNAs |- |acute lymphoblastic leukemia |''CDKN2B-AS1'', ''LOH12CR2'' |- |...") |
|||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] | ||
+ | </div> | ||
+ | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
+ | !width="50"|Name | ||
+ | !width="50"|Transcript ID | ||
+ | !width="50"|Alias | ||
+ | !width="50"|Description | ||
!width="50"|Disease | !width="50"|Disease | ||
− | + | ||
|- | |- | ||
− | | | + | |''DLEU1'' |
− | |'' | + | |[[NONHSAT033797]] |
+ | |deleted in lymphocytic leukemia 1 (non-protein coding) | ||
+ | |"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1" | ||
+ | |chronic lymphocytic leukemia | ||
+ | |- | ||
+ | |''DLEU2'' | ||
+ | |[[NONHSAT033821]] | ||
+ | |deleted in lymphocytic leukemia 2 (non-protein coding) | ||
+ | |"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG" | ||
+ | |chronic lymphocytic leukemia, lymphocytic leukemia, myeloma | ||
+ | |- | ||
+ | |''MIR99AHG'' | ||
+ | |[[ENST00000602580.1]] | ||
+ | |MONC | ||
+ | |mir-99a-let-7c cluster host gene | ||
+ | |myeloid leukemia | ||
+ | |- | ||
+ | |''MIR100HG'' | ||
+ | |[[ENST00000531381.1]] | ||
+ | |"AGD1, lncRNA-N2" | ||
+ | |mir-100-let-7a-2 cluster host gene | ||
+ | |myeloid leukemia | ||
|- | |- | ||
+ | |''MIR155HG'' | ||
+ | |[[NONHSAT081499]] | ||
+ | |"BIC, NCRNA00172" | ||
+ | |MIR155 host gene | ||
|chronic lymphocytic leukemia | |chronic lymphocytic leukemia | ||
− | |||
|- | |- | ||
+ | |''H19'' | ||
+ | |[[NONHSAT017465]] | ||
+ | |"Q96MK8,ENSG00000130600" | ||
+ | |"H19, imprinted maternally expressed transcript (non-protein coding)" | ||
+ | |bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor | ||
+ | |- | ||
+ | |''MEG3'' | ||
+ | |[[NONHSAT039745]] | ||
+ | |"Gtl2, ENSG00000214548" | ||
+ | |maternally expressed 3 (non-protein coding) | ||
+ | |bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes | ||
+ | |- | ||
+ | |''SNHG4'' | ||
+ | |[[NONHSAT104072]] | ||
+ | |"U19H, ENSG00000200959" | ||
+ | |Small nucleolar RNA host gene 4 | ||
+ | |myelodysplastic syndrome | ||
+ | |- | ||
+ | |''CDKN2B-AS1'' | ||
+ | |[[NONHSAT130421]], | ||
+ | [[lnc-C9orf53-2:1]] | ||
+ | |"ANRIL, p15AS, ENSG00000240498" | ||
+ | |CDKN2B antisense RNA 1 | ||
+ | |abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer, | ||
+ | |- | ||
+ | |''BGLT3'' | ||
+ | |[[BGLT3]] | ||
+ | |"LINC01083, BGL3, lncRNA-BGL3" | ||
+ | |beta globin locus transcript 3 (non-protein coding) | ||
+ | |Bcr-Abl-positive leukemia | ||
+ | |- | ||
+ | |''DGCR10'' | ||
+ | |[[DGCR10]] | ||
+ | |DGS-B | ||
+ | |DiGeorge syndrome critical region gene 10 (non-protein coding) | ||
|DiGeorge syndrome | |DiGeorge syndrome | ||
− | |||
|- | |- | ||
− | | | + | |''DGCR11'' |
− | |'' | + | |[[DGCR11]] |
+ | |DGS-D | ||
+ | |DiGeorge syndrome critical region gene 11 (non-protein coding) | ||
+ | |DiGeorge and velo-cardio-facial syndrome | ||
+ | |- | ||
+ | |''DGCR12'' | ||
+ | |[[DGCR12]] | ||
+ | |DGS-E | ||
+ | |DiGeorge syndrome critical region gene 12 (non-protein coding) | ||
+ | |DiGeorge and velo-cardio-facial syndrome | ||
|- | |- | ||
− | + | |''DGCR5'' | |
− | |'' | + | |[[DGCR5]] |
+ | |"NCRNA00037, LINC00037" | ||
+ | |DiGeorge syndrome critical region gene 5 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
|- | |- | ||
− | + | |''DGCR9'' | |
− | |'' | + | |[[DGCR9]] |
+ | |"DGS-A, POM121L5P" | ||
+ | |DiGeorge syndrome critical region gene 9 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
|- | |- | ||
− | | | + | |''LAMP5-AS1'' |
− | + | |[[LAMP5-AS1]] | |
+ | |N/A | ||
+ | |LAMP5 antisense RNA 1 | ||
+ | |leukemogenesis | ||
|- | |- | ||
− | + | |''LOH12CR2'' | |
− | |'' | + | |[[LOH12CR2]] |
+ | |LOH2CR12 | ||
+ | |"loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)" | ||
+ | |tumour suppressor | ||
|- | |- | ||
− | + | |''THRIL'' | |
− | |'' | + | |[[Lnc-DHX37-1:1]] |
+ | |"Linc1992, TCONSN/A00020260, BRI3BP-AS1" | ||
+ | |TNF and HNRNPL related immunoregulatory long non-coding RNA | ||
+ | |Kawasaki disease | ||
|- | |- | ||
− | |||
− | |||
− |
Revision as of 03:44, 30 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
DLEU1 | NONHSAT033797 | deleted in lymphocytic leukemia 1 (non-protein coding) | "LEU1, XTP6, NCRNA00021, LINC00021, BCMS1" | chronic lymphocytic leukemia |
DLEU2 | NONHSAT033821 | deleted in lymphocytic leukemia 2 (non-protein coding) | "LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG" | chronic lymphocytic leukemia, lymphocytic leukemia, myeloma |
MIR99AHG | ENST00000602580.1 | MONC | mir-99a-let-7c cluster host gene | myeloid leukemia |
MIR100HG | ENST00000531381.1 | "AGD1, lncRNA-N2" | mir-100-let-7a-2 cluster host gene | myeloid leukemia |
MIR155HG | NONHSAT081499 | "BIC, NCRNA00172" | MIR155 host gene | chronic lymphocytic leukemia |
H19 | NONHSAT017465 | "Q96MK8,ENSG00000130600" | "H19, imprinted maternally expressed transcript (non-protein coding)" | bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor |
MEG3 | NONHSAT039745 | "Gtl2, ENSG00000214548" | maternally expressed 3 (non-protein coding) | bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes |
SNHG4 | NONHSAT104072 | "U19H, ENSG00000200959" | Small nucleolar RNA host gene 4 | myelodysplastic syndrome |
CDKN2B-AS1 | NONHSAT130421, | "ANRIL, p15AS, ENSG00000240498" | CDKN2B antisense RNA 1 | abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer, |
BGLT3 | BGLT3 | "LINC01083, BGL3, lncRNA-BGL3" | beta globin locus transcript 3 (non-protein coding) | Bcr-Abl-positive leukemia |
DGCR10 | DGCR10 | DGS-B | DiGeorge syndrome critical region gene 10 (non-protein coding) | DiGeorge syndrome |
DGCR11 | DGCR11 | DGS-D | DiGeorge syndrome critical region gene 11 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR12 | DGCR12 | DGS-E | DiGeorge syndrome critical region gene 12 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR5 | DGCR5 | "NCRNA00037, LINC00037" | DiGeorge syndrome critical region gene 5 (non-protein coding) | DiGeorge syndrome |
DGCR9 | DGCR9 | "DGS-A, POM121L5P" | DiGeorge syndrome critical region gene 9 (non-protein coding) | DiGeorge syndrome |
LAMP5-AS1 | LAMP5-AS1 | N/A | LAMP5 antisense RNA 1 | leukemogenesis |
LOH12CR2 | LOH12CR2 | LOH2CR12 | "loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)" | tumour suppressor |
THRIL | Lnc-DHX37-1:1 | "Linc1992, TCONSN/A00020260, BRI3BP-AS1" | TNF and HNRNPL related immunoregulatory long non-coding RNA | Kawasaki disease |